Home | Value-Based Care in Neurology

Featured Articles

Predicting the Onset of Alzheimer Disease Symptoms

Previous studies of in vitro and in vivo aggregation of β-amyloid have suggested that there is a tipping point above which aggregates become nuclei for further aggregation, which proceeds at a constant and predictable rate after the tipping point.

Read more
Psilocybin May Not Be More Efficacious Than a Common Antidepressant

The first-line treatment for major depressive disorder is a selective serotonin reuptake inhibitor, but not all patients respond to this treatment. Psilocybin, a psychedelic made by certain mushrooms, is one alternative that is receiving renewed interest.

Read more

Multiple Sclerosis

Depression May Raise the Risk of Vascular Disease and Mortality in Patients with Multiple Sclerosis

Examining the Association Between Performance on Computerized Tests and Disability Progression in Patients with Relapsing-Remitting Multiple Sclerosis

Disease Severity and Socioeconomic Status in Black and White Patients with Multiple Sclerosis

View More Articles

COVID-19

Use of Functional MRI in a Patient Diagnosed with COVID-19 Experiencing Olfactory and Gustatory Symptoms

The Effect of Disease-Modifying Therapies on the Immune System in Patients with Multiple Sclerosis: Impact on COVID-19 Infection and Vaccination

Immune Reaction to COVID-19 May Play a Role in the Clinical Onset of Multiple Sclerosis

View More Articles